₹3,600 ₹2,750
Certificate off analysis
CAS No 15663-27-1
Ip cisplatin can be administered safely to patients with malignant ascites and may be useful in patients with minimal residual intraperitoneal disease, particularly ovarian carcinoma.
There are no inquiries yet.
©2021 PharmaMartQ. All Rights Reserved. Designed by GCOSOL.